Publicacións nas que colabora con Francisco Gude Sampedro (19)

2022

  1. Immunohistochemical expression of VEGFR1 in non small cell lung carcinomas: Lower VEGFR1 expression is asociated with squamous cell carcinoma subtype and high max SUV values in 18F-FDG PET

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 1, pp. 28-31

  2. Sarcoidosis. Disease progression based on radiological and functional course: Predictive factors

    Heart and Lung, Vol. 56, pp. 62-69

2021

  1. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study

    Oncology Letters, Vol. 22, Núm. 1

  2. The Authors Reply PMC and PMT: Real Medicine and Not Just Biology

    American Journal of Surgical Pathology

2020

  1. Thyroid papillary microtumor: Validation of the (updated) porto proposal assessing sex hormone receptor expression and mutational BRAF gene status

    American Journal of Surgical Pathology, Vol. 44, Núm. 9, pp. 1161-1172

2018

  1. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis

    Virchows Archiv, Vol. 472, Núm. 2, pp. 195-203

2015

  1. Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

    Hepatology Research, Vol. 45, Núm. 4, pp. 423-431

2014

  1. Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas

    Breast Cancer Research and Treatment, Vol. 143, Núm. 1, pp. 81-89

  2. Immunohistochemical evaluation of EGFR expression in lip squamous cell carcinoma. Correlation with clinicopathological characteristics

    Histology and Histopathology, Vol. 29, Núm. 5, pp. 641-648

2012

  1. Breast feeding, parity and breast cancer subtypes in a Spanish cohort

    PLoS ONE, Vol. 7, Núm. 7

2009

  1. Effects of lyophilization on human amniotic membrane

    Acta Ophthalmologica, Vol. 87, Núm. 4, pp. 396-403

  2. Egfr expression correlates with maximum standardized uptake value of 18- fluorodeoxyglucose-pet in squamous cell lung Carcinoma

    Current Radiopharmaceuticals, Vol. 2, Núm. 3, pp. 175-176

  3. La expresión inmunohistoquímica intensa de ciclooxigenasa 2 se asocia inversamente con los valores máximos de SUV en la 18F-FDG-PET de pacientes afectados de carcinomas no microcíticos de pulmón. Relación con otros factores biológicos

    Revista española de medicina nuclear, Vol. 28, Núm. 1, pp. 11-14

2007

  1. Hypoploidy defines patients with poor prognosis in breast cancer

    Oncology Reports, Vol. 17, Núm. 5, pp. 1109-1114

2005

  1. Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study

    Oncology Reports, Vol. 14, Núm. 6, pp. 1527-1531

2004

  1. Liver Disease in Heavy Drinkers with and without Alcohol Withdrawal Syndrome

    Alcoholism: Clinical and Experimental Research, Vol. 28, Núm. 1, pp. 131-136

2002

  1. Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease

    Journal of Hepatology, Vol. 36, Núm. 6, pp. 793-798

  2. Predictors of malignant behaviour in gastrointestinal stromal tumours: A clinicopathological study of 34 cases

    European Journal of Surgery, Vol. 168, Núm. 5, pp. 288-296

1995

  1. Hepatitis C virus antibodies in alcoholic patients

    Revista clínica española, Vol. 195, Núm. 6, pp. 367-372